Spatially mapping the immune landscape of melanoma using imaging mass cytometryDan Moldoveanu, Ian R. Watson, Rached Alkallas et al.|Science Immunology|2022Cited by 131
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanomaSonia V. del Rincón|Journal of Clinical Investigation|2017Cited by 76
The MNK1/2-eIF4E Axis as a Potential Therapeutic Target in MelanomaSathyen A. Prabhu, Sonia V. del Rincón|International Journal of Molecular Sciences|2020Cited by 37
Raw CyTOF images associated with Moldoveanu et al. 2022, Science ImmunologyDan Moldoveanu, Ian R. Watson, LeeAnn Ramsay et al.|Zenodo (CERN European Organization for Nuclear Research)|2022Cited by 1
Multi-platform characterization of cutaneous melanoma from patients treated with immune checkpoint inhibitors.Dan Moldoveanu, Ian R. Watson, Mathieu Lajoie et al.|Journal of Clinical Oncology|2018Cited by 0